🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study was designed to evaluate safety and antitumor activity of HER3-D...
Status
Active Not Recruiting
Location
City of Hope
Start Date
2017-10-30
Trial ID
NCT03260491
Treatments Being Tested
The purpose of this study is to further advance the ability to practice per...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2010-03-01
Trial ID
NCT01042379
Treatments Being Tested
The purpose of this study is to assess the efficacy and safety of pembroliz...
Status
Recruiting
Location
Banner MD Anderson Cancer Center ( Site 0001)
Start Date
2019-12-19
Trial ID
NCT04165070
Activity of patritumab deruxtecan (U3-1402; HER3-DXd) has been shown in a p...
Status
Recruiting
Location
Antoni van Leeuwenhoek
Start Date
2025-03-03
Trial ID
NCT06222489
Treatments Being Tested
Researchers are looking for new ways to treat triple-negative breast cancer...
Status
Recruiting
Location
UCLA Hematology/Oncology - Parkside ( Site 0021)
Start Date
2025-03-20
Trial ID
NCT06797635
This is a phase 1/2 multicenter, open-label umbrella platform study that wi...
Status
Recruiting
Location
University of Arizona Cancer Center-University of Arizona Cancer Center ( Site 8927)
Start Date
2024-08-07
Trial ID
NCT06445972
Treatments Being Tested
Researchers want to learn if MK-1084, the study medicine, can treat advance...
Status
Recruiting
Location
Clermont Oncology Center ( Site 0041)
Start Date
2026-04-30
Trial ID
NCT07286149
Treatments Being Tested
This is a phase 1/2, multicenter, open-label umbrella platform study that w...
Status
Recruiting
Location
University of Arizona Cancer Center-University of Arizona Cancer Center ( Site 6927)
Start Date
2024-09-20
Trial ID
NCT06469944
This study is designed to evaluate the antitumor activity of patritumab der...
Status
Active Not Recruiting
Location
Banner MD Anderson Cancer Center
Start Date
2021-02-02
Trial ID
NCT04619004
Treatments Being Tested
Researchers are investigating new treatments for untreated advanced non-sma...
Status
Recruiting
Location
University of Kentucky ( Site 0019)
Start Date
2025-03-30
Trial ID
NCT06731907
Treatments Being Tested